Flubromazolam just isn't recognized to get any therapeutic use, just isn't on the WHO Design Listing of Crucial Medicines and has not been promoted like a medicinal product or service.The metabolism of flubromazolam is hepatic and is particularly a minimum of partly mediated from the CYP3A4/five and UGT1A4 enzymes [two], which suggests that enzyme